Founded in 2000, TTGG Ventures is among China's earliest market-driven venture capital firms. Headquartered in Hangzhou, the firm also operates offices in Shanghai and Beijing.

For more than two decades, TTGG Ventures has remained committed to its philosophy of “Investors First, Value Investing, and Industry Focus.” Through multiple economic cycles, TTGG Ventures has maintained a long-term focus on intelligent technology, advanced manufacturing, and healthcare, investing in innovative companies with strong technological barriers and high-growth potential.

To date, TTGG Ventures has invested in more than 230 companies, with over 60% of investments fully exited. 55 portfolio companies have successfully listed on the A-share, Hong Kong, or U.S. capital markets, including Sigenergy, Estone, Ronbay Technology, Tianneng Battery Group, ESWIN Material Technology, CCTECH, Jingce Electronic, Dinglong, Hanshow, Bio-Sincerity, Healthgen Biotechnology, and AGS MedTech.

Through long-term industry specialization, TTGG Ventures has established a comprehensive investment portfolio across the hard-tech landscape.